Guo-Fu Hu Selected Research

ribonuclease 4

1/2022

Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Fu Hu Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 01/2005
6	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2009
3	Mouth Neoplasms (Oral Cancer) 05/2014 - 08/2007
3	Carcinogenesis 06/2011 - 02/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2012
2	Colitis 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2007
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 07/2013 - 06/2007
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2012 - 12/2007
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Glioma (Gliomas) 01/2022
1	Hyperplasia 01/2022
1	Inflammation (Inflammations) 11/2021
1	Dysbiosis 01/2021
1	Colitis-Associated Neoplasms 01/2020
1	Leukemia 11/2017
1	Bone Diseases (Bone Disease) 08/2017
1	Squamous Cell Carcinoma of Head and Neck 08/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2016
1	Kidney Diseases (Kidney Disease) 03/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2016
1	Weight Loss (Weight Reduction) 07/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2004
1	Retinoblastoma (Glioblastoma, Retinal) 01/2004

Drug/Important Bio-Agent (IBA)

18	angiogeninIBA 01/2022 - 01/2005
7	Ribonucleases (Ribonuclease)IBA 01/2022 - 06/2007
5	neamineIBA 01/2017 - 03/2009
4	Pharmaceutical PreparationsIBA 01/2017 - 03/2009
3	Monoclonal AntibodiesIBA 01/2022 - 05/2011
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
3	Ribosomal DNA (rDNA)IBA 01/2021 - 05/2011
3	Ribosomal RNAIBA 05/2014 - 05/2011
2	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2011
2	Biological ProductsIBA 03/2016 - 06/2007
2	AndrogensIBA 07/2015 - 10/2013
2	Hormones (Hormone)IBA 07/2015 - 05/2011
2	Phosphotransferases (Kinase)IBA 06/2011 - 01/2004
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 08/2007
2	ornithine decarboxylase antizymeIBA 09/2010 - 08/2007
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	ribonuclease 4IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Transfer RNA (tRNA)IBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	5S Ribosomal RNAIBA 01/2020
1	plexinIBA 01/2020
1	CytokinesIBA 01/2020
1	AntibodiesIBA 11/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2017
1	CD100 antigenIBA 08/2017
1	SuspensionsIBA 05/2016
1	terreinIBA 05/2016
1	Neomycin FDA LinkGeneric 02/2016
1	Cisplatin (Platino)FDA LinkGeneric 07/2015
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2014
1	Androgen Receptors (Androgen Receptor)IBA 10/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2013
1	Apoptosis Inducing FactorIBA 04/2012
1	CyclinsIBA 06/2011
1	Carrier Proteins (Binding Protein)IBA 05/2011
1	Antisense OligonucleotidesIBA 05/2011
1	PolyaminesIBA 09/2010
1	S-adenosyl-3-methylthiopropylamineIBA 09/2010
1	Lysine (L-Lysine)FDA Link 09/2010
1	Histones (Histone)IBA 09/2010
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 09/2010
1	Tobacco Smoke Pollution (Passive Smoking)IBA 10/2008
1	Nicotine FDA Link 10/2008
1	Protein Kinase CIBA 10/2008
1	CarcinogensIBA 10/2008
1	DNA-Activated Protein KinaseIBA 08/2007
1	ZincIBA 08/2007
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005
1	DNA polymerase alpha-primaseIBA 01/2004
1	ThymidineIBA 01/2004
1	Cyclin-Dependent Kinase 2IBA 01/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 10/2013
2	Castration 07/2015 - 10/2013
1	Transplantation 01/2021
1	Oral Administration 01/2021